Bone Density and Menopause: Why Bone Loss Accelerates and How to Protect Your Skeleton
Medically reviewed by Medical Advisory Board Last reviewed 2026-08-03
Estrogen decline drives rapid bone loss — here's what the evidence says about prevention and reversal
Menopause accelerates bone loss: many women lose up to 20% of bone density in the first 5–7 years after estrogen declines. Learn screening, DEXA, nutrition, resistance training, and whether hormone therapy helps.
Estrogen is the primary hormonal regulator of bone remodeling in women. It suppresses osteoclast activity (the cells that break down bone) and supports osteoblast function (the cells that build bone). When estrogen levels decline during perimenopause and menopause, the balance shifts dramatically toward bone resorption — and the skeleton pays the price.
The rate of bone loss is not linear. Women lose 2-3% of bone density per year during the menopausal transition — roughly 10x the rate of age-related loss before menopause. This accelerated phase lasts 5-7 years, then slows to about 1% per year. By age 65, many women have lost 25-30% of their peak bone mass, pushing them into osteopenia or osteoporosis territory.
Want expert help with your hormone health?
We can match you with a board-certified hormone specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →The good news: bone loss is not inevitable. Weight-bearing exercise, adequate calcium and vitamin D, and in some cases pharmacological intervention can slow, halt, or partially reverse bone loss — especially when started early in the menopausal transition.
How Estrogen Protects Bone
Estrogen regulates bone turnover through multiple mechanisms:
- Suppresses osteoclasts: Estrogen promotes osteoclast apoptosis (programmed cell death), limiting the lifespan of bone-resorbing cells. Without estrogen, osteoclasts live longer and resorb more bone.
- Supports osteoblasts: Estrogen stimulates osteoblast proliferation and differentiation, promoting new bone formation.
- Regulates calcium absorption: Estrogen enhances intestinal calcium absorption and reduces renal calcium excretion, maintaining the calcium supply needed for bone mineralization.
- Modulates cytokines: Estrogen suppresses pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) that stimulate bone resorption. Postmenopausal estrogen withdrawal creates a pro-inflammatory environment that accelerates bone loss.
Timeline of Bone Loss During Menopause
Bone loss follows a predictable pattern around the menopausal transition:
- Perimenopause (2-5 years before final period): Bone loss begins as estrogen fluctuates. Rate: 0.5-1% per year.
- Early postmenopause (first 5-7 years): Accelerated loss of 2-3% per year, primarily from trabecular bone (spine, wrist, hip). This is the critical intervention window.
- Late postmenopause (7+ years after): Loss slows to ~1% per year, now affecting cortical bone as well.
Peak bone mass is typically reached by age 30. Women who enter menopause with higher peak bone mass have more reserve before crossing the osteopenia or osteoporosis threshold.
Perimenopause vs. Postmenopause vs. Early and Surgical Menopause: How the Decline Differs
The pace and urgency of bone loss depends heavily on when menopause happens and why it happens, not just on the fact that estrogen has declined. The Menopause Society (the renamed North American Menopause Society) publishes clinical guidance that treats these as distinct scenarios rather than one uniform "menopause and bone" picture.
- Perimenopause: Bone loss can begin before periods stop entirely, driven by erratic estrogen swings rather than a simple steady decline. Because cycles are often still occurring, many women assume bone density isn't yet a concern at this stage — but DEXA data in perimenopausal women frequently shows measurable loss has already started, which is why reviewing risk factors (not necessarily scheduling a scan yet) is reasonable earlier than most people expect.
- Natural postmenopause: The steepest, most consistent loss occurs in the first 5-7 years after the final period, once estrogen has settled at its new lower baseline and osteoclast activity outpaces osteoblast activity most sharply. This remains the single highest-yield window for starting exercise, nutrition, and — where appropriate — hormone therapy.
- Early or premature menopause (before age 45, spontaneous or medically induced): Reaching low estrogen years ahead of the average means more total years of accelerated bone loss before the skeleton would otherwise have entered this phase. This is a major reason clinical guidance generally supports considering hormone therapy through at least the average age of natural menopause (around 51) for women in this group, absent a contraindication — the goal is limiting the cumulative bone (and cardiovascular) impact of an unusually long low-estrogen exposure.
- Surgical menopause (bilateral oophorectomy): Removing both ovaries causes an abrupt drop in estrogen rather than the gradual decline of natural menopause, and the bone-loss response in the months that follow can be correspondingly faster. This abruptness is why surgical menopause is generally treated as its own risk category in bone-health guidance, distinct from age-matched natural menopause.
The practical takeaway: women in the early, premature, or surgical categories generally shouldn't wait for the standard screening age. Talk to a doctor about an earlier baseline DEXA and whether hormone therapy fits your situation — see when to get a DEXA scan for the specific age and risk-factor guidance.
Evidence-Based Strategies to Protect Bone
- Weight-bearing and resistance exercise: The single most effective non-pharmacological intervention. High-impact activities (jumping, jogging, stair climbing) and progressive resistance training increase bone density by 1-3% at the spine and hip over 12-18 months (Bone, 2019). The LIFTMOR trial showed high-intensity resistance training was safe and effective even for women with osteopenia/osteoporosis.
- Calcium: 1,000-1,200 mg/day from food and supplements combined. Food sources are preferred — dairy, sardines, leafy greens, tofu (calcium-set). Excessive supplementation (>1,500 mg/day) may increase cardiovascular risk.
- Vitamin D: 1,000-4,000 IU/day to maintain serum 25(OH)D above 40 ng/mL. Vitamin D is essential for calcium absorption — without adequate D, only 10-15% of dietary calcium is absorbed vs. 30-40% with optimal levels.
- Protein: 1.0-1.2 g/kg/day. Adequate protein supports the collagen matrix that calcium mineralizes onto.
- Hormone therapy: Estrogen therapy (ET) or combined hormone therapy (HT) prevents bone loss and reduces fracture risk by 30-40%. The WHI confirmed this benefit. For women within 10 years of menopause with no contraindications, bone protection is an additional benefit of HT prescribed for vasomotor symptoms.
When to Get a DEXA Scan
The USPSTF recommends bone density screening (DEXA scan) for all women aged 65+ and for younger postmenopausal women with risk factors. However, waiting until 65 misses the critical window of accelerated bone loss. Consider earlier testing if you have:
- Early menopause (before age 45)
- Family history of osteoporosis or hip fracture
- Low body weight (BMI <20)
- History of fracture after age 50
- Long-term corticosteroid use (>3 months)
- Smoking or excessive alcohol use
- Conditions that affect calcium absorption (celiac disease, IBD)
How to test your hormones at home
You don't need a lab appointment to check your own hormones — a few at-home kits mail you a collection kit and return physician-reviewed results online within days:
Prefer to order direct? The Everlywell Men's or Women's Health hormone test uses a CLIA-certified lab, physician-reviewed results, and prepaid return shipping.
Frequently Asked Questions
How can I check bone density at home?
There is no validated at-home bone density test. Online tools like FRAX (Fracture Risk Assessment Tool) can estimate your 10-year fracture probability using clinical risk factors, but they do not measure bone density directly. A DEXA scan at a radiology facility or hospital is the only clinical standard for measuring bone mineral density. Some pharmacies offer ultrasound heel scans as screening tools, but these are not diagnostic.
When is it too late to build bone density?
It is never too late to improve bone health. While rebuilding lost bone becomes more difficult with age, studies show that weight-bearing exercise and resistance training can increase bone density by 1-3% even in women over 70. Pharmacological treatments (bisphosphonates, denosumab, romosozumab) can increase bone density by 5-10% over 2-3 years regardless of age. The earlier you start, the more bone mass you preserve.
How to increase bone density naturally?
The most effective natural strategies are: (1) progressive resistance training and high-impact weight-bearing exercise 3-4x/week, (2) adequate calcium from food (1,000-1,200 mg/day from dairy, sardines, leafy greens), (3) vitamin D supplementation to maintain levels above 40 ng/mL, (4) adequate protein (1.0-1.2 g/kg/day), (5) avoiding excessive alcohol and smoking, and (6) ensuring adequate magnesium, vitamin K2, and boron intake.
How to improve bone density during menopause?
During the menopausal transition, the most impactful approach combines resistance exercise (the LIFTMOR protocol showed spine BMD increases of 2.9% in postmenopausal women), adequate calcium and vitamin D, and — when appropriate — hormone therapy, which prevents bone loss and reduces fracture risk by 30-40%. Starting early in the transition preserves more bone than waiting until significant loss has occurred.
Does estrogen help with bone density?
Yes. Estrogen is the primary hormonal protector of bone in women. The WHI trial confirmed that estrogen therapy reduces hip fractures by 33% and vertebral fractures by 34%. Estrogen works by suppressing osteoclast activity (bone breakdown), supporting osteoblast function (bone formation), and enhancing calcium absorption. When estrogen declines during menopause, bone resorption accelerates sharply.
Does early or surgical menopause increase osteoporosis risk more than natural menopause at the average age?
Generally yes, because the total number of years spent at low estrogen is greater. Early or premature menopause (before 45) and surgical menopause (bilateral oophorectomy) both mean the loss of estrogen's bone-protective effect starts earlier in life than the average natural menopause around age 51 — leaving more years for accelerated bone loss to accumulate before typical screening would otherwise begin. This is why clinical guidance generally supports considering hormone therapy through at least the average age of natural menopause for women in these groups, and why an earlier baseline DEXA scan is often appropriate rather than waiting until 65.
Related Bone Health Guides
Topic updates
Get the weekly hormone optimization roundup
Testosterone, thyroid, cortisol, estrogen, menopause, perimenopause, libido, and hormone testing.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. As an Amazon Associate we earn from qualifying purchases. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.